The newly published Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium establishes elevated levels of CRP, D-dimers and reduced platelet count are significantly associated with in-hospital mortality, which supports our own data. The gene discussed is CRP; the disease is Venous thrombosis.